DOV Pharmaceutical Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
23
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
1
DOV Pharmaceutical General Information
Description
Developer of novel therapeutics intended to treat disorders of the central nervous system. The company engages in drug development and discovery programs focused on monoamine reuptake inhibitors, enabling medical professionals to treat neuropsychiatric disorders ranging from depression and attention deficit hyperactivity disorder better.
Contact Information
Website
www.dovpharm.comCorporate Office
- P. O. Box 1320
- Little Falls, NJ 07424
- United States
Corporate Office
- P. O. Box 1320
- Little Falls, NJ 07424
- United States
DOV Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DOV Pharmaceutical Patents
DOV Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20090069374-A1 | Novel 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments | Inactive | 06-Jun-2007 | ||
| US-20080194696-A1 | Norepinephrine, serotonin and dopamine reuptake inhibitors such as 1-(3,4-dichlorophenyl)bicyclo[3.1.0]hexan-3-amine, used for the treatment and/or prevention of nervous system disorders; antidepressants; anxiolytic agents | Inactive | 07-Nov-2006 | ||
| US-20080269348-A1 | Norepinephrine, serotonin and dopamine reuptake inhibitors such as 1-(3,4-dichlorophenyl)bicyclo[3.1.0]hexan-3-amine, used for the treatment and/or prevention of nervous system disorders; antidepressants; anxiolytic agents | Inactive | 07-Nov-2006 | ||
| JP-2010509334-A | Novel arylbicyclo [3.1.0] hexylamines and methods and compositions for their preparation and use | Pending | 07-Nov-2006 | ||
| CA-2705457-A1 | Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use | Inactive | 07-Nov-2006 | C07C211/41 |
DOV Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DOV Pharmaceutical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
DOV Pharmaceutical Acquisitions (1)
DOV Pharmaceutical’s most recent deal was a Reverse Merger with Euthymics Bioscience. The deal was made on 22-Jul-2010.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Euthymics Bioscience | 22-Jul-2010 | Reverse Merger | Drug Discovery |
DOV Pharmaceutical Exits (1)
DOV Pharmaceutical’s most recent exit was on 22-Jul-2010 from Euthymics Bioscience. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Euthymics Bioscience | 22-Jul-2010 | Completed |
|
DOV Pharmaceutical FAQs
-
When was DOV Pharmaceutical founded?
DOV Pharmaceutical was founded in 1995.
-
Where is DOV Pharmaceutical headquartered?
DOV Pharmaceutical is headquartered in Little Falls, NJ.
-
What is the size of DOV Pharmaceutical?
DOV Pharmaceutical has 23 total employees.
-
What industry is DOV Pharmaceutical in?
DOV Pharmaceutical’s primary industry is Drug Discovery.
-
Is DOV Pharmaceutical a private or public company?
DOV Pharmaceutical is a Private company.
-
What is DOV Pharmaceutical’s current revenue?
The current revenue for DOV Pharmaceutical is .
-
How much funding has DOV Pharmaceutical raised over time?
DOV Pharmaceutical has raised $110M.
-
Who are DOV Pharmaceutical’s investors?
Merlin BioMed Group and OrbiMed have invested in DOV Pharmaceutical.
-
When was DOV Pharmaceutical acquired?
DOV Pharmaceutical was acquired on 22-Jul-2010.
-
Who acquired DOV Pharmaceutical?
DOV Pharmaceutical was acquired by Euthymics Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
